Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Virogin Biotech | 2021 | Series D | Undisclosed | Vancouver |
| Codasip | 2025 | Venture - Series Unknown | Undisclosed | Munich |
| Petlibro | 2023 | Series B | $14.0M | Santa Clara |
| TytoCare | 2023 | Series E | $49.0M | New York |
| Sanegene Bio | 2025 | Series B | $110.0M | Woburn |
| FJ Dynamics | 2024 | Series B | Undisclosed | Singapore |
| Bite Micro | 2026 | Series B | $14.5M | Shenzhen |
| HT Aero | 2026 | Series Unknown | $200.0M | Tianhe |
| Zhongke Tiansuan | 2026 | Angel | $14.5M | Beijing |
| Geson Technology | 2026 | Seed | Undisclosed | Shenzhen |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Virogin Biotech | Series D | Undisclosed | Vancouver, Canada |
| 2 | Codasip | Venture - Series Unknown | Undisclosed | Munich, Germany |
| 3 | Petlibro | Series B | $14.0M | Santa Clara, United States |
| 4 | TytoCare | Series E | $49.0M | New York, United States |
| 5 | Sanegene Bio | Series B | $110.0M | Woburn, United States |
| 6 | FJ Dynamics | Series B | Undisclosed | Singapore, Singapore |
| 7 | Bite Micro | Series B | $14.5M | Shenzhen, China |
| 8 | HT Aero | Series Unknown | $200.0M | Tianhe, China |
| 9 | Zhongke Tiansuan | Angel | $14.5M | Beijing, China |
| 10 | Geson Technology | Seed | Undisclosed | Shenzhen, China |
Virogin Biotech is an antineoplastic drug developer.
Codasip is a processor solutions company which uniquely helps developers to differentiate their products
Innovative Pet Products & Services
TytoCare is a telehealth platform for AI-powered and on-demand remote medical examinations.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
FJ Dynamics is a global robotic company that provides digital and autonomous solutions for agriculture, construction, and other sectors.
Better Micro Medical is a medical device company that offers comprehensive solutions for peripheral vascular and structural heart disease.
HT Aero aspires to be the pioneer of urban air mobility (UAM) and is dedicated to producing safe and intelligent electric flying vehicles.
Zhongke Tiansuan is a provider of space-based intelligent computing and application systems.
Geson Technology is an innovative enterprise focusing on the research and mass production of embodied intelligence.
Glenro provides precision motion control, power grid intelligent sensing, and laser micro-nano manufacturing.
Laser Link is a laser communication company that focuses on development of precision optical-mechanical products for commercial aircraft.
Zhejiang Kecong provides comprehensive solutions for mobile robot autonomous navigation control systems.
Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
KargoBot is a technology company that develops and deploys autonomous freight transport systems for logistics and cargo movement.
Visinex Technology is a technology company that manufactures and develops application processor chips.
X Square is a company aiming to create a universal brain-cerebellum system for robots, encompassing capabilities from perception to action.
Inspire-Robots is a supplier of robot core components and intelligent operation solutions.
AI² Robotics develops general-purpose intelligent robots that extend artificial intelligence into real-world physical tasks.
Edrive Space develops aerospace propulsion systems for the aerospace industry.
Unbounded Dynamics is a robotics and embodied intelligence startup that develops operational intelligence for robots and autonomous systems.
Regend Therapeutics focuses on the human organ regenerative medicine business
Transcend Vivoscope is a biotechnology company that specializes in providing advanced microscopy imaging products and solutions.
Kai Medtech is a marketing and sales company for vascular intervention medical devices.
Lanxin Computing is a high-performance chip design company that focuses on the research and development of CPUs with RISC-V ecosystems.
Shenzhen Capital Group has invested in 277 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Shenzhen Capital Group's top investment sectors include Artificial Intelligence (AI), Robotics, Manufacturing, Health Care, Medical Device. The firm invests across 49 different industry categories.
Among tracked funding rounds, Galaxy Bot received $363.9M in a Series Unknown round. Shenzhen Capital Group's total known invested capital is $5.7B.
Shenzhen Capital Group's average investment size is $32.2M across its portfolio of 277 companies.
Recent Shenzhen Capital Group portfolio additions include Virogin Biotech, Codasip, Petlibro, TytoCare, Sanegene Bio. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors